EE05306B1 - Arlitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning hendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks - Google Patents
Arlitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning hendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseksInfo
- Publication number
- EE05306B1 EE05306B1 EEP200300240A EEP200300240A EE05306B1 EE 05306 B1 EE05306 B1 EE 05306B1 EE P200300240 A EEP200300240 A EE P200300240A EE P200300240 A EEP200300240 A EE P200300240A EE 05306 B1 EE05306 B1 EE 05306B1
- Authority
- EE
- Estonia
- Prior art keywords
- thiophenecarboxamide
- furan
- evaluated
- preparation
- pharmaceutical formulation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10061876A DE10061876A1 (de) | 2000-12-12 | 2000-12-12 | Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
PCT/EP2001/013958 WO2002048131A1 (fr) | 2000-12-12 | 2001-11-29 | Amides d'acides furane et thiophene carboxyliques aryles ayant un effet de blocage de canal de potassium |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200300240A EE200300240A (et) | 2003-08-15 |
EE05306B1 true EE05306B1 (et) | 2010-06-15 |
Family
ID=7666837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300240A EE05306B1 (et) | 2000-12-12 | 2001-11-29 | Arlitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning hendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks |
Country Status (30)
Country | Link |
---|---|
US (1) | US6982279B2 (fr) |
EP (1) | EP1349846B1 (fr) |
JP (1) | JP4252798B2 (fr) |
KR (1) | KR20030061846A (fr) |
CN (1) | CN1225463C (fr) |
AR (1) | AR032781A1 (fr) |
AT (1) | ATE288906T1 (fr) |
AU (2) | AU2002235743B2 (fr) |
BR (1) | BR0116084A (fr) |
CA (1) | CA2431095A1 (fr) |
CZ (1) | CZ20031633A3 (fr) |
DE (2) | DE10061876A1 (fr) |
DK (1) | DK1349846T3 (fr) |
EE (1) | EE05306B1 (fr) |
ES (1) | ES2236335T3 (fr) |
HK (1) | HK1061850A1 (fr) |
HR (1) | HRP20030469A2 (fr) |
HU (1) | HUP0303665A3 (fr) |
IL (2) | IL156314A0 (fr) |
MX (1) | MXPA03004770A (fr) |
NO (1) | NO329163B1 (fr) |
NZ (1) | NZ526383A (fr) |
PL (1) | PL362410A1 (fr) |
PT (1) | PT1349846E (fr) |
RS (1) | RS50336B (fr) |
RU (1) | RU2275366C2 (fr) |
SK (1) | SK287464B6 (fr) |
TW (1) | TWI288134B (fr) |
WO (1) | WO2002048131A1 (fr) |
ZA (1) | ZA200304091B (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL208713B1 (pl) * | 2001-06-11 | 2011-05-31 | Virochem Pharma Inc | Związek stanowiący pochodną tiofenu, kompozycja farmaceutyczna zawierająca taki związek i jego zastosowanie |
US8329924B2 (en) * | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
PT1569929E (pt) | 2002-12-10 | 2010-06-18 | Virochem Pharma Inc | Compostos e métodos para o tratamento ou prevenção de infecções por flavivírus |
GB0315950D0 (en) | 2003-06-11 | 2003-08-13 | Xention Discovery Ltd | Compounds |
EP1493739A1 (fr) * | 2003-07-03 | 2005-01-05 | Warner-Lambert Company LLC | Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
GB0324269D0 (en) * | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
GB0412986D0 (en) | 2004-06-10 | 2004-07-14 | Xention Discovery Ltd | Compounds |
US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
US7576212B2 (en) | 2004-12-09 | 2009-08-18 | Xention Limited | Thieno[2,3-B] pyridines as potassium channel inhibitors |
EA016071B1 (ru) * | 2005-05-13 | 2012-01-30 | Вирокем Фарма Инк. | Соединения и способы лечения или предотвращения флавивирусных инфекций |
JP4943429B2 (ja) * | 2005-07-22 | 2012-05-30 | メルク・シャープ・エンド・ドーム・コーポレイション | カリウムチャネル阻害剤 |
GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
NZ572231A (en) * | 2006-04-27 | 2010-12-24 | Sanofi Aventis Deutschland | Inhibitors of the task-1 and task-3 ion channel |
RS52874B (en) | 2006-11-15 | 2013-12-31 | Vertex Pharmaceuticals Incorporated | THYOPHEN ANALYSIS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS |
CA2699157A1 (fr) | 2007-09-10 | 2009-03-19 | Calcimedica, Inc. | Composes modulant le calcium intracellulaire |
ITMI20071971A1 (it) * | 2007-10-10 | 2009-04-11 | Altergon Sa | Composizione farmaceutica per la somministrazione sublinguale di progesterone, e metodo per la sua preparazione |
WO2009076454A2 (fr) | 2007-12-12 | 2009-06-18 | Calcimedica, Inc. | Compositions qui modulant le calcium intracellulaire |
MX2011002149A (es) | 2008-08-27 | 2011-04-05 | Calcimedica Inc | Compuestos que modulan el calcio intracelular. |
GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
US8524763B2 (en) | 2008-09-22 | 2013-09-03 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
US8143269B2 (en) | 2008-10-03 | 2012-03-27 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
JP2012516344A (ja) * | 2009-01-30 | 2012-07-19 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 結晶質n−{(1s)−2−アミノ−1−[(3−フルオロフェニル)メチル]エチル}−5−クロロ−4−(4−クロロ−1−メチル−1h−ピラゾール−5−イル)−2−チオフェンカルボキサミド塩酸塩 |
US8618307B2 (en) | 2009-09-16 | 2013-12-31 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
AU2011265047B2 (en) | 2010-06-07 | 2014-10-23 | Novomedix, Llc | Furanyl compounds and the use thereof |
US9079891B2 (en) | 2010-08-27 | 2015-07-14 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
GB201105659D0 (en) | 2011-04-01 | 2011-05-18 | Xention Ltd | Compounds |
NO3175985T3 (fr) | 2011-07-01 | 2018-04-28 | ||
EP2806865A1 (fr) | 2012-01-27 | 2014-12-03 | Gilead Sciences, Inc. | Thérapies de combinaison à l'aide de bloqueurs de canaux ioniques au sodium tardifs et de bloqueurs de canaux ioniques au potassium |
US9512116B2 (en) | 2012-10-12 | 2016-12-06 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
CN103012381B (zh) * | 2013-01-10 | 2015-01-07 | 山东大学 | 苯基呋喃类化合物、其制备方法及在制备抗心律失常药物中的应用 |
KR101721490B1 (ko) * | 2014-07-30 | 2017-03-30 | 한국생명공학연구원 | 페닐 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 세포증식성 질병의 예방 또는 치료용 약학적 조성물 |
EP3366683A1 (fr) * | 2017-02-28 | 2018-08-29 | Acousia Therapeutics GmbH | Amides, acetamides et ureas cycliques pour ouvris les voies de calcium |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
DK41193D0 (da) * | 1993-04-07 | 1993-04-07 | Neurosearch As | Ionkanalaabnere |
IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US5670504A (en) | 1995-02-23 | 1997-09-23 | Merck & Co. Inc. | 2,6-diaryl pyridazinones with immunosuppressant activity |
US6083986A (en) | 1996-07-26 | 2000-07-04 | Icagen, Inc. | Potassium channel inhibitors |
US5935945A (en) | 1996-10-31 | 1999-08-10 | Merck & Co., Inc. | Methods of treating or preventing cardiac arrhythmia |
US5969017A (en) | 1996-10-31 | 1999-10-19 | Merck & Co., Inc. | Methods of treating or preventing cardiac arrhythmia |
US6013664A (en) * | 1996-11-27 | 2000-01-11 | Bayer Aktiengesellschaft | Microbicidal agents based on thiophene-2-carboxylic acid derivatives |
EP1003713A1 (fr) * | 1997-08-05 | 2000-05-31 | American Home Products Corporation | Analogues d'acide anthranilique |
NZ503809A (en) * | 1997-12-19 | 2002-04-26 | Schering Ag | Ortho-anthranilamide derivatives as anti-coagulants |
US6333337B1 (en) * | 1998-01-27 | 2001-12-25 | Icagen, Inc. | Potassium channel inhibitors |
AU2300699A (en) * | 1998-02-17 | 1999-08-30 | Ono Pharmaceutical Co. Ltd. | Amidino derivatives and drugs containing the same as the active ingredient |
EP0960882A1 (fr) * | 1998-05-19 | 1999-12-01 | Hoechst Marion Roussel Deutschland GmbH | Acylguanidines de thienyl et leur utilisation comme inhibiteurs de la résorptionosseuse et comme antagonistes du récepteur de la vitronectine |
EP1082315A1 (fr) | 1998-06-05 | 2001-03-14 | Icagen, Inc. | Inhibiteurs des canaux de potassium |
AU754204B2 (en) | 1998-09-01 | 2002-11-07 | Bristol-Myers Squibb Company | Potassium channel inhibitors and method |
WO2000075129A1 (fr) * | 1999-06-07 | 2000-12-14 | Shire Biochem Inc. | Inhibiteurs d'integrine thiophene |
WO2003018585A1 (fr) * | 2001-08-24 | 2003-03-06 | Pharmacia & Upjohn Company | Heteroaryl-7-aza[2.2.1]bicycloheptanes substitues destines au traitement de maladies |
-
2000
- 2000-12-12 DE DE10061876A patent/DE10061876A1/de not_active Withdrawn
-
2001
- 2001-11-29 CA CA002431095A patent/CA2431095A1/fr not_active Abandoned
- 2001-11-29 DE DE50105337T patent/DE50105337D1/de not_active Expired - Lifetime
- 2001-11-29 EP EP01985832A patent/EP1349846B1/fr not_active Expired - Lifetime
- 2001-11-29 RU RU2003121236/04A patent/RU2275366C2/ru not_active IP Right Cessation
- 2001-11-29 MX MXPA03004770A patent/MXPA03004770A/es active IP Right Grant
- 2001-11-29 EE EEP200300240A patent/EE05306B1/xx not_active IP Right Cessation
- 2001-11-29 WO PCT/EP2001/013958 patent/WO2002048131A1/fr active IP Right Grant
- 2001-11-29 IL IL15631401A patent/IL156314A0/xx unknown
- 2001-11-29 PL PL01362410A patent/PL362410A1/xx not_active IP Right Cessation
- 2001-11-29 CN CNB018204007A patent/CN1225463C/zh not_active Expired - Fee Related
- 2001-11-29 SK SK725-2003A patent/SK287464B6/sk not_active IP Right Cessation
- 2001-11-29 CZ CZ20031633A patent/CZ20031633A3/cs unknown
- 2001-11-29 BR BR0116084-2A patent/BR0116084A/pt not_active Application Discontinuation
- 2001-11-29 KR KR10-2003-7007875A patent/KR20030061846A/ko active IP Right Grant
- 2001-11-29 AU AU2002235743A patent/AU2002235743B2/en not_active Ceased
- 2001-11-29 NZ NZ526383A patent/NZ526383A/en unknown
- 2001-11-29 PT PT01985832T patent/PT1349846E/pt unknown
- 2001-11-29 DK DK01985832T patent/DK1349846T3/da active
- 2001-11-29 AT AT01985832T patent/ATE288906T1/de active
- 2001-11-29 ES ES01985832T patent/ES2236335T3/es not_active Expired - Lifetime
- 2001-11-29 AU AU3574302A patent/AU3574302A/xx active Pending
- 2001-11-29 RS YUP-425/03A patent/RS50336B/sr unknown
- 2001-11-29 HU HU0303665A patent/HUP0303665A3/hu unknown
- 2001-11-29 JP JP2002549662A patent/JP4252798B2/ja not_active Expired - Fee Related
- 2001-12-10 AR ARP010105720A patent/AR032781A1/es active IP Right Grant
- 2001-12-10 TW TW090130471A patent/TWI288134B/zh not_active IP Right Cessation
- 2001-12-12 US US10/012,338 patent/US6982279B2/en not_active Expired - Fee Related
-
2003
- 2003-05-27 ZA ZA200304091A patent/ZA200304091B/en unknown
- 2003-06-04 NO NO20032535A patent/NO329163B1/no not_active IP Right Cessation
- 2003-06-04 IL IL156314A patent/IL156314A/en not_active IP Right Cessation
- 2003-06-10 HR HR20030469A patent/HRP20030469A2/hr not_active Application Discontinuation
-
2004
- 2004-07-06 HK HK04104841A patent/HK1061850A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE05306B1 (et) | Arlitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning hendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks | |
EE05220B1 (et) | Bis-arüülühend, seda sisaldav ravimpreparaat ning ühendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks | |
ZA200206905B (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same. | |
BR0115810B1 (pt) | composições cosméticas, dermatológicas e farmacêuticas isentas de tensoativos. | |
AU3752601A (en) | Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof | |
HUP0400837A3 (en) | 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them | |
HUP0204474A3 (en) | 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use | |
EE200300207A (et) | Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon | |
HUP0400636A3 (en) | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof | |
HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
HUP0301146A3 (en) | 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use | |
HUP0204101A3 (en) | 3-aminoquinazolin-2,4-dione antibacterial agents, pharmaceutical compositions containing them and their use | |
HUP0402566A3 (en) | C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them | |
HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
AU7645701A (en) | Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides | |
EE200100391A (et) | Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon | |
HUP0400967A3 (en) | Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them | |
FR2809730B1 (fr) | Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique | |
IL154240A0 (en) | 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods | |
FR2831440B1 (fr) | Composition cosmetique, renfermant un derive de la dhea et un agent apaisant | |
EE200200551A (et) | Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine | |
EE200200480A (et) | Memnopeptiidühend, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon | |
HUP0303379A3 (en) | Acid-sensitive compounds, use thereof and pharmaceutical compositions containing them | |
EP1389204A4 (fr) | Nouveaux derives de sulfonamides, leurs intermediaires, leurs procedes de preparation et composition pharmaceutique les contenant | |
HUP0302255A3 (en) | Sulfonamide derivatives, pharmaceutical compositions containing them and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20111129 |